1. Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study.
- Author
-
AbouGalala, Khalid, Elsayed, Basant, Elmarasi, Mohamed, Kotob, Mona, Taha, Reham, Abbasher, Fardous, Amarah, Ahmed, El Hamawi, Mariam, Albayat, Soha S., Abdulmajeed, Jazeel, Sallam, Mohamed A. H., Al-Shamali, Maha H. M., Al-Romaihi, Hamad E., Bansal, Devendra, Musa, Omran A. H., Farag, Elmoubasher, Al-Thani, Mohammed H. J., Chivese, Tawanda, and Emara, Mohamed M.
- Subjects
- *
COVID-19 , *CROSS-sectional method , *LOGISTIC regression analysis , *COVID-19 pandemic , *NEUROLOGICAL disorders - Abstract
This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF